Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1456]

Study reveals global disparities in cervical cancer rates among women with HIV

Study reveals global disparities in cervical cancer rates among women with HIV

Human-on-a-chip model tests cancer drug efficacy and toxicity for therapeutic index

Human-on-a-chip model tests cancer drug efficacy and toxicity for therapeutic index

Molecular analysis could improve the early detection and prevention of endometrial cancer

Molecular analysis could improve the early detection and prevention of endometrial cancer

Carboplatin & paclitaxel chemotherapy alone should remain standard treatment for endometrial cancer

Carboplatin & paclitaxel chemotherapy alone should remain standard treatment for endometrial cancer

Radiation plus chemotherapy doesn't improve endometrial cancer recurrence-free survival

Radiation plus chemotherapy doesn't improve endometrial cancer recurrence-free survival

A 'one-two punch' to wipe out cancerous ovarian cells

A 'one-two punch' to wipe out cancerous ovarian cells

ASCO 2019: New standard regimen for women with uterine carcinosarcomas

ASCO 2019: New standard regimen for women with uterine carcinosarcomas

ASCO 2019: NCI-MATCH trial finds the combination of dabrafenib and trametinib effective

ASCO 2019: NCI-MATCH trial finds the combination of dabrafenib and trametinib effective

ASCO 2019: Earlier ovarian cancer diagnoses and treatment seen after ACA implementation

ASCO 2019: Earlier ovarian cancer diagnoses and treatment seen after ACA implementation

ASCO 2019: Drug targeting DNA damage response shows promise against cancers of anus and genitals

ASCO 2019: Drug targeting DNA damage response shows promise against cancers of anus and genitals

More from ecancer